{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03124",
      "entity_text" : "KEL antigen",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10141" ],
      "TissueType" : [ "tissuelist:TS-0290" ]
    }
  },
  "verbose_text" : "Of all of these models, the KEL model system, which employs a beta-globin promoter to drive expression of the clinically relevant human KEL antigen specifically on murine RBCs (KEL RBCs), currently provides the most compelling model capable of recapitulating key clinical features of RBC alloimmunization, including the ability to induce antibodies (Abs) capable of clearing transfused RBCs.",
  "reading_complete" : "2020-08-04T11:58:24Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:55:39Z",
  "trigger" : "expression",
  "evidence" : [ "expression of the clinically relevant human KEL antigen" ],
  "pmc_id" : "6004516",
  "score" : 0
}